La société genevoise Covalence publie aujourd’hui son troisième ranking annuel de réputation éthique, qui classe les entreprises enregistrant le meilleur score et celles ayant le plus progressé au cours de l’année 2007. Les principaux résultats à travers les dix secteurs…
Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical…
Bayer and GlaxoSmithKline have been named and shamed via adverts in the medical and pharmaceutical press after falling foul of the Association of the British Pharmaceutical Industry’s Code of Practice. The ABPI’s Prescription Medicines Code of Practice Authority slapped Bayer…
Unless delegates to a high-profile summit on diabetes in Kenya last week knew it had been paid for by the world's biggest maker of insulin, they would have been none the wiser when they left. The conference, in the lush…
A report on the ethical reputations of the world's largest pharmaceutical companies which gives UK-based multinational GlaxoSmithKline (GSK) the top score, has been heavily criticised for ignoring one of the most contentious ethical issues around, animal testing. Ethically ranking animal-testing…
GlaxoSmithKline is at the top of ethical-monitoring firm Covalence's ranking list, followed by Bristol-Myers Squibb and Johnson & Johnson. The quarterly report, which ranks the top 10 highest-ranking pharmas, reveals that the amount of revenue a company earns does not…
In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and…
The latest ethical reputations of the world's largest pharmaceutical companies have been revealed, with GlaxoSmithKline (GSK) emerging as big pharma's Mother Theresa, according to a recently-released compilation by Geneva-based ethical-monitoring firm Covalence. Interestingly, earning power and ethical nature do not…
British pharmaceutical giant GlaxoSmithKline (GSK) have announced the development of a vaccine for use in African meningitis belt countries that the company says will never make a profit or even recoup its R&D costs. The vaccine is Globorixâ„¢, primarily a…
